Piper Sandler analyst David Westenberg lowered the firm’s price target on Illumina (ILMN) to $185 from $190 following quarterly results. The firm keeps an Overweight rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina price target lowered to $98 from $145 at UBS
- Here’s Why Cathie Wood Walked Away from PLTR and ACHR Stocks
- Illumina’s Resilience Amid Market Challenges: A Buy Rating Supported by Strong Consumable Segment and Strategic Adjustments
- Illumina price target lowered to $87 from $92 at Canaccord
- Illumina price target lowered to $100 from $136 at Morgan Stanley